Target intelligence / Profile preview

Influenza A virus hemagglutinin stem (HA stem) (HA stem)

Target
HA stem
Molecular classification
Viral surface glycoprotein, Class I viral fusion protein, Antigenic epitope
01

Overview

The Influenza A virus hemagglutinin (HA) stem is a highly conserved region of the virus's primary surface glycoprotein, serving as a critical component of the viral entry machinery (Nature, 2009, 458(7238):597-601). While the globular head of the HA protein undergoes frequent antigenic drift, the stem region—comprised of the HA2 subunit and the proximal portion of HA1—remains largely unchanged across diverse influenza subtypes (Science, 2011, 333(6044):850-856). This conservation makes the HA stem a primary target for "universal" influenza vaccines and broadly neutralizing monoclonal antibodies (bnAbs) that aim to provide protection against multiple seasonal and pandemic strains (Frontiers in Immunology, 2018, 9:2645). Mechanistically, the stem mediates the fusion of the viral envelope with the host endosomal membrane through a pH-triggered conformational change (Journal of Virology, 2013, 87(17):9742-9754). Therapeutic agents, such as the monoclonal antibodies CR6261 and MEDI8852, bind to this epitope to stabilize the pre-fusion structure, thereby preventing the release of the viral genome into the host cytoplasm (Cell, 2016, 166(3):596-608). Despite its potential, the HA stem is characterized by low immunodominance, presenting a challenge for vaccine design that requires specialized strategies to redirect the immune response away from the head (NPJ Vaccines, 2019, 4:17).

Other names
Hemagglutinin stalkHA stalkHA2 subunitConserved HA stem regionHemagglutinin stem epitope
02

Mechanism of action

Binding to the conserved stem region to inhibit the pH-induced conformational change required for viral-host membrane fusion, thereby blocking viral entry (Nature, 2009; Science, 2011).

03

Biological functions

Viral-host membrane fusionViral entry into host cellsConformational rearrangement for genome release
04

Disease associations

Influenza A infectionSeasonal influenzaPandemic influenza
05

Safety considerations

Low natural immunogenicity (immunodominance of the HA head)Potential for viral escape mutations in the HA2 subunitAntibody-dependent enhancement (theoretical concern in influenza)Requirement for high therapeutic doses of monoclonal antibodies
06

Interacting drugs

CR6261

5 more in the full profile.

07

Biomarkers

Anti-HA stem antibody titers (measured by ELISA)Microneutralization assay titersStem-binding antibody competition assays

Beyond the preview

Go deeper on Influenza A virus hemagglutinin stem (HA stem) (HA stem).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Influenza A virus hemagglutinin stem (HA stem) (HA stem).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call